Thyroseq testing (CANCER)
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36C24821D0025
- Awardee
-
Cytopath Biopsy Lab Inc. UEI KC5VWAGMNLT6
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 5 $790,000 obligated
Award facts
- Opportunity
-
- 6640--Laboratory: Thyroid Cancer Test Pre-Solicitation · 36C24821Q0213 · Posted Dec 11, 2020
- 6640--Laboratory: Thyroid Cancer Test Special Notice · Posted Dec 11, 2020
- Combined order value
- $790,000 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 94% used
- $838,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq molecular diagnostic testing services to support cancer screening and diagnosis programs for veterans.
Under this $838,000 single-award IDC, Cblpath will deliver firm fixed price task orders to perform ThyroSeq genetic testing at their facilities in Port Chester, New York and Gobernador Piñero, Puerto Rico. The task orders, valued at $168,000, $200,000, $120,000, and $94,000, have completion dates ranging from January 2022 to January 2025. The contract does not utilize any small business set-asides. Through this IDC and related Blanket Purchase Agreements, Cblpath has established a multi-year portfolio of federal awards to provide specialized ThyroSeq cancer diagnostic services to VA healthcare networks and the Defense Health Agency.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Thyroseq testing (CANCER) | Veterans Integrated Service Network 8 (VHA) | $228,000 | |
| Thyroseq testing (CANCER) | Veterans Integrated Service Network 8 (VHA) | $148,000 | |
| Thyroseq testing (CANCER) | Veterans Integrated Service Network 8 (VHA) | $200,000 | |
| Thyroseq testing (CANCER) | Veterans Integrated Service Network 8 (VHA) | $120,000 | |
| Thyroseq cancer test (60 each for 12 months) | Veterans Integrated Service Network 8 (VHA) | $94,000 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Funding Only Action | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C24821D0025?
36C24821D0025 was awarded to Cytopath Biopsy Lab Inc. by Veterans Integrated Service Network 8 (Veterans Health Administration) on February 1, 2021.
How much is contract 36C24821D0025 worth?
Orders under 36C24821D0025 have obligated $790,000. 36C24821D0025's own ceiling is $838,000.
How many orders have been placed under contract 36C24821D0025?
5 orders have been placed under 36C24821D0025, the latest on February 1, 2025.
Who can order from contract 36C24821D0025?
36C24821D0025 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 36C24821D0025 competed?
The extent of competition for 36C24821D0025 was competed under sap. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV